CHASAM

The Obama Health Plan's Impact on Pfizer: Final Nail in the Coffin or New Beginning?

Pfizer will become a better and stronger company over the next three to five years. I personally believe that Mr. Kindler is doing an excellent job running the company. While everyone is crowing about leadership, the purchase of WYE shows me some strong leadership; a clear view of the future. WYE provides PFE with a quantum leap into the repidly growing vaccine business. WYE's Prevnar is the largest selling vaccine in the world, with sales continuing to grow. Prevnar II is in the works and promises to be equally lucrative and I might add equally efficacious. It also makes the PFE/WYE combination the undisputed leader in Animal Health, another segment that is growing faster than the general pharma industry. Those who banter on incessantly about the expiration of the Lipitor patent must believe that PFE is going to roll over and let the generics take it all. Don't bet on it.
Despite the above mentioned challenges, the pharmaceutical industry will not cease to exist. When the dust settles, Pfizer will still be #1.